The role and techniques of vascular resection

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Surgical resection for pancreatic adenocarcinoma remains the only single modality with the potential for cure or long-term survival. With improvements in surgical techniques and perioperative management, the morbidity and mortality associated with pancreatic resection has significantly improved. Nonetheless, the long-term oncologic outcomes of patients with pancreatic cancer have remained relatively poor despite these advances due to the biological aggressiveness of the disease and its widely disseminated nature at the time of diagnosis. Identification of patient- and tumor-specific risk factors and use of novel resectability classifications have now facilitated prediction of patients who may derive benefit from surgical procedures. Furthermore, significant improvements in the activity of systemic and locoregional therapies has resulted in an increase in the number of patients that may benefit from selectively aggressive operations with the need for more complex vascular procedures to accomplish oncologically effective resections. Any surgeons involved in the operative care of patients with pancreatic cancer should therefore have significant training and experience in these advanced techniques and have a full comprehensive understanding of expected risks and outcomes of such interventions.

Original languageEnglish (US)
Title of host publicationMultimodality Management of Borderline Resectable Pancreatic Cancer
PublisherSpringer International Publishing
Pages203-222
Number of pages20
ISBN (Electronic)9783319227801
ISBN (Print)9783319227795
DOIs
StatePublished - Dec 10 2015

Fingerprint

Blood Vessels
Pancreatic Neoplasms
Patient Care
Adenocarcinoma
Morbidity
Survival
Mortality
Neoplasms
Therapeutics

Keywords

  • Arterial resection and reconstruction
  • Borderline resectable
  • Celiac artery resection
  • Hepatic artery resection
  • Locally advanced
  • Multivisceral resection
  • Pancreatic cancer
  • Portal vein resection
  • SMA resection
  • SMV Resection
  • Surgical resection
  • Venous resection and reconstruction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Truty, M. (2015). The role and techniques of vascular resection. In Multimodality Management of Borderline Resectable Pancreatic Cancer (pp. 203-222). Springer International Publishing. https://doi.org/10.1007/978-3-319-22780-1_13

The role and techniques of vascular resection. / Truty, Mark.

Multimodality Management of Borderline Resectable Pancreatic Cancer. Springer International Publishing, 2015. p. 203-222.

Research output: Chapter in Book/Report/Conference proceedingChapter

Truty, M 2015, The role and techniques of vascular resection. in Multimodality Management of Borderline Resectable Pancreatic Cancer. Springer International Publishing, pp. 203-222. https://doi.org/10.1007/978-3-319-22780-1_13
Truty M. The role and techniques of vascular resection. In Multimodality Management of Borderline Resectable Pancreatic Cancer. Springer International Publishing. 2015. p. 203-222 https://doi.org/10.1007/978-3-319-22780-1_13
Truty, Mark. / The role and techniques of vascular resection. Multimodality Management of Borderline Resectable Pancreatic Cancer. Springer International Publishing, 2015. pp. 203-222
@inbook{e51b15f0120242ed805b70365ee436ac,
title = "The role and techniques of vascular resection",
abstract = "Surgical resection for pancreatic adenocarcinoma remains the only single modality with the potential for cure or long-term survival. With improvements in surgical techniques and perioperative management, the morbidity and mortality associated with pancreatic resection has significantly improved. Nonetheless, the long-term oncologic outcomes of patients with pancreatic cancer have remained relatively poor despite these advances due to the biological aggressiveness of the disease and its widely disseminated nature at the time of diagnosis. Identification of patient- and tumor-specific risk factors and use of novel resectability classifications have now facilitated prediction of patients who may derive benefit from surgical procedures. Furthermore, significant improvements in the activity of systemic and locoregional therapies has resulted in an increase in the number of patients that may benefit from selectively aggressive operations with the need for more complex vascular procedures to accomplish oncologically effective resections. Any surgeons involved in the operative care of patients with pancreatic cancer should therefore have significant training and experience in these advanced techniques and have a full comprehensive understanding of expected risks and outcomes of such interventions.",
keywords = "Arterial resection and reconstruction, Borderline resectable, Celiac artery resection, Hepatic artery resection, Locally advanced, Multivisceral resection, Pancreatic cancer, Portal vein resection, SMA resection, SMV Resection, Surgical resection, Venous resection and reconstruction",
author = "Mark Truty",
year = "2015",
month = "12",
day = "10",
doi = "10.1007/978-3-319-22780-1_13",
language = "English (US)",
isbn = "9783319227795",
pages = "203--222",
booktitle = "Multimodality Management of Borderline Resectable Pancreatic Cancer",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - The role and techniques of vascular resection

AU - Truty, Mark

PY - 2015/12/10

Y1 - 2015/12/10

N2 - Surgical resection for pancreatic adenocarcinoma remains the only single modality with the potential for cure or long-term survival. With improvements in surgical techniques and perioperative management, the morbidity and mortality associated with pancreatic resection has significantly improved. Nonetheless, the long-term oncologic outcomes of patients with pancreatic cancer have remained relatively poor despite these advances due to the biological aggressiveness of the disease and its widely disseminated nature at the time of diagnosis. Identification of patient- and tumor-specific risk factors and use of novel resectability classifications have now facilitated prediction of patients who may derive benefit from surgical procedures. Furthermore, significant improvements in the activity of systemic and locoregional therapies has resulted in an increase in the number of patients that may benefit from selectively aggressive operations with the need for more complex vascular procedures to accomplish oncologically effective resections. Any surgeons involved in the operative care of patients with pancreatic cancer should therefore have significant training and experience in these advanced techniques and have a full comprehensive understanding of expected risks and outcomes of such interventions.

AB - Surgical resection for pancreatic adenocarcinoma remains the only single modality with the potential for cure or long-term survival. With improvements in surgical techniques and perioperative management, the morbidity and mortality associated with pancreatic resection has significantly improved. Nonetheless, the long-term oncologic outcomes of patients with pancreatic cancer have remained relatively poor despite these advances due to the biological aggressiveness of the disease and its widely disseminated nature at the time of diagnosis. Identification of patient- and tumor-specific risk factors and use of novel resectability classifications have now facilitated prediction of patients who may derive benefit from surgical procedures. Furthermore, significant improvements in the activity of systemic and locoregional therapies has resulted in an increase in the number of patients that may benefit from selectively aggressive operations with the need for more complex vascular procedures to accomplish oncologically effective resections. Any surgeons involved in the operative care of patients with pancreatic cancer should therefore have significant training and experience in these advanced techniques and have a full comprehensive understanding of expected risks and outcomes of such interventions.

KW - Arterial resection and reconstruction

KW - Borderline resectable

KW - Celiac artery resection

KW - Hepatic artery resection

KW - Locally advanced

KW - Multivisceral resection

KW - Pancreatic cancer

KW - Portal vein resection

KW - SMA resection

KW - SMV Resection

KW - Surgical resection

KW - Venous resection and reconstruction

UR - http://www.scopus.com/inward/record.url?scp=85012149161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012149161&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-22780-1_13

DO - 10.1007/978-3-319-22780-1_13

M3 - Chapter

AN - SCOPUS:85012149161

SN - 9783319227795

SP - 203

EP - 222

BT - Multimodality Management of Borderline Resectable Pancreatic Cancer

PB - Springer International Publishing

ER -